Stay updated on GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. This is an administrative update with no changes to study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-01-14T04:05:38.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    No significant changes to the study content or locations; only minor UI elements appeared (cookie banner). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-07T02:04:42.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The changes appear to be minor UI updates, including the Last Update timestamp; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-31T00:31:48.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a Locations section including Pennsylvania and removed the older Pennsylvania Locations; the HHS Vulnerability Disclosure entry was removed in revision v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:39:02.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    No significant additions or deletions detected; the page content and study details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-09T14:48:38.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The update appears to involve minor user-interface adjustments and a timestamp change on the Study Details page; there are no changes to core study content such as eligibility criteria, outcomes, or study design. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-02T11:48:04.000Z thumbnail image

Stay in the know with updates to GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.